Copyright 2009 Medical News Today Latest Cervical Cancer / HPV Vaccine News From Medical News Today. http://www.medicalnewstoday.com/sections/cervical_cancer/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Tue, 24 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171959.php http://www.medicalnewstoday.com/articles/171959.php As the intense debate continues over new cancer test guidelines, the Obama administration is trying to protect health care reform from the controversy's fallout. The Breast Cancer Tue, 24 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171940.php http://www.medicalnewstoday.com/articles/171940.php Steve Pagliuca, a candidate in the Democratic primary for the U.S. Senate seat formerly held by Sen. Edward Kennedy (D-Mass.), "made the boldest move yet" in the race when he recently used health care reform "to try to set himself apart from his principal rivals," Boston Globe columnist Steve Lehigh writes. Abortion Mon, 23 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171798.php http://www.medicalnewstoday.com/articles/171798.php Although "it took well over a year," the "federal government has finally realized that it was out of bounds to require immigrant women" to be vaccinated against the human papillomavirus, a Los Angeles Times editorial states. Cervical Cancer / HPV Vaccine Mon, 23 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/171813.php http://www.medicalnewstoday.com/articles/171813.php New guidelines on mammograms and pap smears set off a fierce debate. The New York Times reports: "Two new recommendations, calling for delaying the start and reducing the frequency of screening for breast and cervical cancer, have been met with anger and confusion from some corners, not to mention a measure of political posturing. Breast Cancer Sun, 22 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/171742.php http://www.medicalnewstoday.com/articles/171742.php Women should have their first cervical cancer screening at age 21 and can be rescreened less frequently than previously recommended, according to newly revised evidence-based guidelines issued today by The American College of Obstetricians and Gynecologists (ACOG) and published in the December issue of Obstetrics & Gynecology. Cervical Cancer / HPV Vaccine Thu, 19 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171476.php http://www.medicalnewstoday.com/articles/171476.php Starting Dec. 14, the U.S. will no longer require female immigrants seeking permanent resident status to be vaccinated against the human papillomavirus, the Centers for Disease Control and Prevention announced on Friday, the AP/San Francisco Chronicle reports. Cervical Cancer / HPV Vaccine Wed, 18 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171319.php http://www.medicalnewstoday.com/articles/171319.php The following summarizes selected women's health-related blog entries. ~ "DeGette: Stupak Agenda Is Much Wider Restrictions on Abortion," Brian Beutler, Talking Points Memo: Rep. Diana DeGette (D-Colo.) "takes issue" with Rep. Bart Stupak's (D-Mich. Abortion Sat, 14 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170926.php http://www.medicalnewstoday.com/articles/170926.php SNM applauds the Centers for Medicare & Medicaid Services' (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions. "CMS' decision to expand coverage of FDG PET for the initial treatment strategy evaluation of cervical cancer is important for patient care," said Michael M. Graham, Ph.D., M.D., president of SNM. Cervical Cancer / HPV Vaccine Fri, 13 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170679.php http://www.medicalnewstoday.com/articles/170679.php A study by Norwegian researchers published November 13 in the open-access journal PLoS Genetics reports that cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes. Research suggests that specific genetic changes are critical steps in the progression of the disease towards an aggressive and treatment-resistant state. Cervical Cancer / HPV Vaccine Wed, 11 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170511.php http://www.medicalnewstoday.com/articles/170511.php A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. Cervical Cancer / HPV Vaccine Tue, 10 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/170411.php http://www.medicalnewstoday.com/articles/170411.php Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. Cervical Cancer / HPV Vaccine Tue, 10 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170400.php http://www.medicalnewstoday.com/articles/170400.php Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. Published in this week's (Nov. 9) Proceedings of the National Academy of Sciences, the findings offer hope for the 500,000 women around the world who are diagnosed with cervical cancer each year. Half of them will not survive. Cervical Cancer / HPV Vaccine Fri, 06 Nov 2009 20:00:00 PST http://www.medicalnewstoday.com/articles/170154.php http://www.medicalnewstoday.com/articles/170154.php Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI). Cervical Cancer / HPV Vaccine Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170062.php http://www.medicalnewstoday.com/articles/170062.php An experimental vaccine to treat precancerous vulvar growths eliminated the growths in nine of 20 women participating in a small trial, according to a study published in the New England Journal of Medicine, Reuters reports. Women's Health / Gynecology Fri, 06 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170038.php http://www.medicalnewstoday.com/articles/170038.php Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden. Cervical Cancer / HPV Vaccine Thu, 05 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169896.php http://www.medicalnewstoday.com/articles/169896.php A new paper to be published in BJOG: An International Journal of Obstetrics and Gynaecology outlines a number of ongoing questions and challenges related to HPV vaccination. These include the decision to limit vaccination to adolescent girls, and the importance of continued screening. In 2008, the government launched a nationwide immunisation programme designed to protect British women against the devastating impact of cervical cancer. Cervical Cancer / HPV Vaccine Thu, 05 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169898.php http://www.medicalnewstoday.com/articles/169898.php A survey of more than 1,200 primary care doctors in the U.S. found that less than 25% made Pap test recommendations that were fully in line with major guidelines, according to a study published Monday in the Annals of Internal Medicine, Reuters reports. Cervical Cancer / HPV Vaccine Wed, 04 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169834.php http://www.medicalnewstoday.com/articles/169834.php Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects of chemotherapy. "This represents the power of personalized medicine. Cancer / Oncology Tue, 03 Nov 2009 11:00:00 PST http://www.medicalnewstoday.com/articles/169648.php http://www.medicalnewstoday.com/articles/169648.php The National Institute for Health and Clinical Excellence (NICE) has today (28 October) published final guidance recommending the use of topotecan in combination with cisplatin as a treatment option for women with recurrent or stage IVB cervical cancer who have not previously received cisplatin. Cervical Cancer / HPV Vaccine Tue, 03 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169578.php http://www.medicalnewstoday.com/articles/169578.php Early Releases 1. Report Questions Whether Family Health History Disclosure Improves Clinical Decision Making Systematic collection of family history is a potentially important step in personalizing healthcare. Family health history can reveal important information about a patient, and may prompt specialist investigation or positive lifestyle changes. Hypertension Mon, 02 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/169449.php http://www.medicalnewstoday.com/articles/169449.php The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." Health researchers say this makes it difficult to learn about each group's specific needs, particularly in regard to cancer, one of the leading killers of Asian-Americans. Cancer / Oncology Thu, 29 Oct 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169107.php http://www.medicalnewstoday.com/articles/169107.php According to a study published Wednesday in the Journal of the American Medical Association, conventional Pap tests, which have been used since the 1940s, and ThinPrep, a test approved in 1996 that represents 70% of the U.S. cervical cancer market, are equally effective at detecting precancerous cells, Cervical Cancer / HPV Vaccine Wed, 28 Oct 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/168991.php http://www.medicalnewstoday.com/articles/168991.php Nearly eighty per cent of girls say that having the HPV vaccine makes them think twice about the risks of having sex, according to a study published in the British Journal of Cancer. The survey - the first to focus on girls' views of the vaccine rather than their parents' - showed that, despite speculation that the vaccine could make girls more likely to start having sex younger, it highlighted the risks of sex for the overwhelming majority. Cervical Cancer / HPV Vaccine Wed, 28 Oct 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/168875.php http://www.medicalnewstoday.com/articles/168875.php Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center have just released the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers. The new recommendations represent the first wave of an effort by M. D. Breast Cancer Tue, 27 Oct 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/168766.php http://www.medicalnewstoday.com/articles/168766.php More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID). Cervical Cancer / HPV Vaccine